Hepatic Cell Carcinoma
5 clinical trials · Condition
◉ Watch Hepatic Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| HRYZ-T102 TCR-T Cell for AFP Positive Advanced HCC and Other Solid Tumors (NCT06515314) | Shanghai Ruiliyuan Biotechnology Co., Ltd. | 2024-10-17 |
| Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis (NCT06265272) | Massachusetts General Hospital | 2023-12-10 |
| The Value of circRNAs (hsa_circ_0004001) in Early Diagnosis of HCC (NCT06042842) | Assiut University | 2023-11-01 |
| A Phase 1, Single-arm, Open-label, Dose-escalation Study of JWATM204 as T Cell-targeted Immunotherapy in the Treatment Amongst Subjects With Advanced Hepatocellular Carcinoma (NCT06144385) | Shanghai Ming Ju Biotechnology Co., Ltd. | 2022-03-24 |
| Effectiveness of Drug Eluting TACE in Primary HCC (NCT04048317) | Assiut University | 2019-09-01 |
Track Hepatic Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.